Cargando…
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
Since the establishment of the biomarker-based A-T-N (Amyloid/Tau/Neurodegeneration) framework in Alzheimer’s disease (AD), the diagnosis of AD has become more precise, and cerebrospinal fluid tests and positron emission tomography examinations based on this framework have become widely accepted. Ho...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206048/ https://www.ncbi.nlm.nih.gov/pubmed/35306613 http://dx.doi.org/10.1007/s12264-022-00836-7 |